Does Wegovy Affect the Nexplanon Implant? What the Evidence Says

The misconception that gets Nexplanon users worried, and why it doesn't apply here

The anxiety around Wegovy and contraception is understandable. Headlines about GLP-1 medicines and pill failure have circulated widely, and if you're relying on the implant you might reasonably wonder whether you face the same risk. You don't, and here's why.

The concern with oral contraceptives comes down to absorption. Wegovy slows gastric emptying, which means pills spend longer in the stomach before reaching the small intestine where absorption happens. For a hormone tablet, that delay can reduce how reliably the contraceptive dose enters your bloodstream. Changes to cycle regularity on semaglutide sometimes prompt this question too, but the mechanism is different from the absorption issue.

Nexplanon sidesteps the problem entirely. The small flexible rod sits under the skin of the upper arm and releases etonogestrel continuously into your bloodstream, no swallowing, no stomach, no intestinal wall. Wegovy has no plausible route to interrupt that process. A similar principle applies to the hormonal IUD, which is also not swallowed. The NHS guidance on weight-management injections distinguishes between these methods and oral contraceptives precisely because the delivery route matters.

So if your only contraception is the implant, you do not need to add a barrier method when starting Wegovy or when your dose increases. That's the evidence-based position, and it contrasts directly with the guidance for combined-pill users.

What rapid weight loss on Wegovy might do to your body, and what it can't change

Even with the absorption question off the table, significant weight loss does have physiological effects worth knowing about. Oestrogen is partly stored in adipose (fat) tissue. As fat mass falls, oestrogen stored there can be released back into circulation, which sometimes shows up as temporary changes in period patterns, heavier, lighter, or slightly shifted cycles. Some people also notice changes in appetite and taste perception that feel surprising if you weren't warned.

None of these effects compromise Nexplanon's contraceptive action. The implant's etonogestrel release is independent of your oestrogen levels and your fat stores. What it means is that any shift in your cycle while using the implant during Wegovy treatment is more likely to reflect the hormonal rebalancing that comes with weight change than any failure of your contraception.

If your periods change noticeably after starting semaglutide, mention it at your next clinical review. A quick check of what's normal during active weight loss can save a lot of unnecessary worry. Our clinical team fields questions like this regularly.

It is also worth keeping in mind that weight loss can improve fertility in some people, even when periods seem irregular. If pregnancy is not your intention, your current contraception should be confirmed as appropriate for your circumstances, with or without Wegovy in the picture.

What to tell your prescriber, and what to check before you start

Before any prescriber approves Wegovy, they need a clear picture of your health, and that includes your contraception. Telling them you have a Nexplanon implant is straightforward and takes a moment, but it matters: it confirms which MHRA guidance applies to you and removes any ambiguity about whether you need additional precautions.

One practical habit worth building: check when your implant is due for replacement. The standard Nexplanon lasts three years. If yours is approaching that window while you're losing weight on semaglutide, the timing of your replacement appointment is a sensible thing to flag. A minute now with your diary can prevent a gap in cover later.

The interaction between Wegovy and HRT is a separate topic that some people on the implant also ask about, particularly if they're perimenopausal; your prescriber can talk through that too. For anyone curious about how semaglutide works more broadly, the semaglutide overview on our site covers the mechanism and evidence, and the Wegovy treatment page explains the UK-licensed dose pathway.

Wegovy is a prescription-only medicine. NHS England's guidance on weight-management injections notes contraception considerations specifically, and the NHS semaglutide medicines page summarises what patients should tell their prescriber before starting. Both are worth a read if you'd like the detail from official sources.

If you'd like to explore whether Wegovy is clinically suitable for you, you can find information about treatment options and check your eligibility through a free consultation with our prescribers.